BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

241 related articles for article (PubMed ID: 7404479)

  • 1. Relationship of ADP-induced fibrinogen binding to platelet shape change and aggregation elucidated by use of colchicine and cytochalasin B.
    Peerschke EI; Zucker MB
    Thromb Haemost; 1980 Feb; 43(1):58-60. PubMed ID: 7404479
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibitors of ADP-induced platelet aggregation prevent fibrinogen binding to rabbit platelets and cause rapid deaggregation and dissociation of bound fibrinogen.
    Harfenist EJ; Packham MA; Kinlough-Rathbone RL; Mustard JF
    J Lab Clin Med; 1981 May; 97(5):680-8. PubMed ID: 6783712
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Adrenaline and adenosine diphosphate-induced platelet aggregation require shape change. Importance of pseudopods.
    Milton JG; Frojmovic MM
    J Lab Clin Med; 1984 Nov; 104(5):805-15. PubMed ID: 6387013
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of the interactions of fibrinogen and soluble fibrin with washed rabbit platelets stimulated with ADP.
    Harfenist EJ; Packham MA; Mustard JF
    Thromb Haemost; 1985 Apr; 53(2):183-7. PubMed ID: 3927504
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ca+2 mobilization and fibrinogen binding of platelets refractory to adenosine diphosphate stimulation.
    Peerschke EI
    J Lab Clin Med; 1985 Aug; 106(2):111-22. PubMed ID: 2991399
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Colloidal gold labelling of fibrinogen receptors in epinephrine- and ADP-activated platelet suspensions.
    Oliver JA; Albrecht RM
    Scanning Microsc; 1987 Jun; 1(2):745-56. PubMed ID: 3616571
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Platelet aggregation caused by dithiothreitol.
    Zucker MB; Masiello NC
    Thromb Haemost; 1984 Feb; 51(1):119-24. PubMed ID: 6232725
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Binding of fibrinogen to ADP-treated platelets. Comparison of plasma fibrinogen fractions and early plasmic fibrinogen derivatives.
    Peerschke EI; Galanakis DK
    J Lab Clin Med; 1983 Mar; 101(3):453-60. PubMed ID: 6827176
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Epinephrine-induced aggregation of rabbit platelets refractory to ADP.
    Lalau Keraly C; Kinlough-Rathbone RL; Mustard JF
    Thromb Haemost; 1985 Jun; 53(3):366-71. PubMed ID: 2996167
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Correlation between fibrinogen binding to human platelets and platelet aggregability.
    Peerschke EI; Zucker MB; Grant RA; Egan JJ; Johnson MM
    Blood; 1980 May; 55(5):841-7. PubMed ID: 6767512
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Regulation of platelet aggregation by post-fibrinogen binding events. Insights provided by dithiothreitol-treated platelets.
    Peerschke EI
    Thromb Haemost; 1995 May; 73(5):862-7. PubMed ID: 7482417
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expression of fibrinogen on the surface of ADP-stimulated platelets: comparison of human and rabbit platelets.
    Harfenist EJ; Packham MA; Mustard JF
    Thromb Haemost; 1988 Apr; 59(2):319-22. PubMed ID: 3388301
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Microtubule coils versus the surface membrane cytoskeleton in maintenance and restoration of platelet discoid shape.
    White JG; Rao GH
    Am J Pathol; 1998 Feb; 152(2):597-609. PubMed ID: 9466587
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Deficiency of (33P)2MeS-ADP binding sites on platelets with secretion defect, normal granule stores and normal thromboxane A2 production. Evidence that ADP potentiates platelet secretion independently of the formation of large platelet aggregates and thromboxane A2 production.
    Cattaneo M; Lombardi R; Zighetti ML; Gachet C; Ohlmann P; Cazenave JP; Mannucci PM
    Thromb Haemost; 1997 May; 77(5):986-90. PubMed ID: 9184415
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification of two distinct adenosine diphosphate receptors in human platelets.
    Colman RW; Figures WR; Colman RF; Morinelli TA; Niewiarowski S; Mills DC
    Trans Assoc Am Physicians; 1980; 93():305-16. PubMed ID: 6264660
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Exposure of platelet fibrinogen receptors by ADP and epinephrine.
    Bennett JS; Vilaire G
    J Clin Invest; 1979 Nov; 64(5):1393-401. PubMed ID: 574143
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Platelet-platelet recognition during aggregation: distinct mechanisms determined by the release reaction.
    Agam G; Livne A
    Thromb Haemost; 1984 Apr; 51(2):145-9. PubMed ID: 6740546
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Platelet prostaglandin production and its implications.
    Smith JB; Ingerman CM; Silver MJ
    Adv Prostaglandin Thromboxane Res; 1976; 2():747-53. PubMed ID: 983875
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ticlopidine selectively inhibits human platelet responses to adenosine diphosphate.
    Cattaneo M; Akkawat B; Lecchi A; Cimminiello C; Capitanio AM; Mannucci PM
    Thromb Haemost; 1991 Dec; 66(6):694-9. PubMed ID: 1665598
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of activators and inhibitors on human blood platelets: study by freeze-fracturing technique and electron microscopy.
    Ariad S; Dvilansky A; Nathan I
    Int J Tissue React; 1984; 6(4):311-5. PubMed ID: 6441789
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.